CoreAge Rx vs Eden
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Eden head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Eden
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 91 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
That doesn't make Eden a bad call — it's best for readers who prioritize a vetted, high-transparency provider over the lowest sticker price. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | Eden | |
|---|---|---|
| Brief Score | 94/100 (A) | 91/100 (A−) |
| Semaglutide | $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published | $198/mo all-in — $99/mo for the medication plus the $99/mo Eden membership it cannot be bought without ($138 the first month, when membership is $39); compounded |
| Tirzepatide | $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published | $298/mo all-in — $199/mo for the medication plus the required $99/mo membership ($238 the first month); compounded |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Fallingprice falling |
CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.
Eden: Re-read 28 August 2026 and restated: Eden advertises compounded semaglutide at $99/mo and tirzepatide at $199/mo, but its own footnote says medication cannot be bought without an Eden membership that costs $39 the first month and $99/mo after — so the real monthly cost is $198 and $298. That is below the $239 and $349 we carried before, so the direction is down even after adding the fee back in. Brand-name Ozempic, Zepbound and Mounjaro ($1,399/mo) and Wegovy ($1,695/mo) are sold here too.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.